Federal: Other MH Policy
Official titleRelease of the 2025 National Survey on Drug Use and Health: Using Data to Drive the Great American Recovery
Federal · Relevance score 35 of 100 (tangential). low impact.
This summary is informational and is not legal advice. Read the source text before acting on it.
What this policy change does.
- Jurisdiction
- Federal
- Published
- July 27, 2026
- Impact score
- 35 of 100, from analysis of the full text: tangential
- Primary source
- SAMHSA
Impact on your practice
While important for understanding the national mental health landscape, this epidemiological data release does not directly affect therapist reimbursement, licensing, or practice operations. It may inform workforce planning and funding advocacy.
Key facts
- SAMHSA released 2025 National Survey on Drug Use and Health data
- Survey tracks substance use, addiction, and mental health prevalence nationally
- Over 1.5 million lives lost to overdose and suicide in past two decades
- Data intended to inform policy and treatment planning decisions
What it would mean for a practice.
This epidemiological snapshot reveals a bifurcated clinical landscape that will shape your patient census and case complexity over the next 2–3 years. Among adolescents (12–17), the data is encouraging: depression, suicidal ideation, and substance use disorders all declined from 2021 to 2025. However, 11.2% of adolescents still engaged in non-suicidal self-harm in the past year—a newly measured metric that will likely drive increased referrals to your practice for trauma-informed DBT and emotion regulation work. For your adult caseload (18+), expect a more complex picture. While most mental health indicators remained stable, suicide indicators increased across all adult age groups. Specifically, 5.3% of adults reported serious suicidal ideation (13.9 million people), and this upward trend suggests you will see more acutely suicidal clients, requiring enhanced safety assessment protocols, more frequent sessions, and careful documentation of suicide risk management. If your practice bills Medicaid or commercial plans, document that your clients fall within these high-risk categories to justify medical necessity for intensive outpatient or teletherapy services. Additionally, 45 million Americans meet criteria for substance use disorder, with marijuana use disorder affecting 19.3 million—the largest single category. If you do not currently specialize in dual-diagnosis (SUD + mental illness), this data justifies investment in motivational interviewing training or referral partnerships with addiction specialists. Your revenue opportunity lies in positioning your practice as equipped to treat the 20.6% of adults with any mental illness, particularly the 6.9% with serious mental illness, who will require longer treatment courses and justify higher session frequencies for parity compliance arguments.
Background
SAMHSA released the 2025 National Survey on Drug Use and Health results on July 27, 2026, marking the earliest-ever release of this annual report. For over 40 years, NSDUH has been the federal government's gold-standard epidemiological tool, tracking substance use, addiction, and mental health prevalence across the United States. This 2025 release is the first since 2020 that provides five consecutive years of trend data (2021–2025), allowing policymakers and clinicians to assess whether the mental health and addiction crisis is stabilizing or worsening. The broader context is the Trump administration's "Make America Healthy Again" initiative, which frames behavioral health as central to addressing the chronic disease epidemic. The timing is significant: the 2025 data will inform federal and state funding priorities for treatment infrastructure, workforce development, and prevention programs over the next fiscal years. For therapists, this means policymakers and insurance networks will be citing these prevalence figures to justify coverage mandates, session limits, and reimbursement levels. Understanding what the data actually shows—versus how it may be misrepresented in network policies—is critical to defending your clinical judgment.
What you should do
- Review your current intake assessment tools to ensure you are routinely screening for suicidal ideation, intent, and plan in all adult clients, given the upward trend in all three suicide indicators. Document these screens in every chart, as insurance audits will increasingly demand evidence of suicide risk assessment when claims are submitted for adults with any mental health diagnosis.
- If you serve adolescents, add non-suicidal self-harm screening to your intake packet immediately. The NSDUH now measures this (11.2% prevalence), which means managed care organizations will soon require it in their quality metrics and prior authorization forms. Train your clinical staff on the distinction between suicidal and non-suicidal self-harm, as they carry different treatment protocols and insurance implications.
- Develop or strengthen referral partnerships with addiction treatment providers. With 45 million Americans meeting SUD criteria and marijuana use disorder being the most common, your practice will receive increased dual-diagnosis referrals. If you are not trained in addiction treatment, establish clear pathways to co-treat with an LCDC or CSAC, or document referrals to specialized programs. This improves retention, reduces denials for concurrent SUD treatment, and protects you from liability if a client's substance use is unaddressed.
- Audit your documentation of medical necessity for session frequency. The data showing increased suicidal ideation in adults justifies 2–3 sessions per week for acute cases; ensure your notes explicitly reference risk level, impairment, and symptom severity using language aligned with the GAD-7 and PHQ-9 scales mentioned in the NSDUH. This creates a defensible record if an insurance company denies additional sessions.
- Monitor your state Medicaid agency's website and your managed care contracts for policy updates citing 2025 NSDUH data. Expect to see new prior authorization criteria, carve-outs for adolescent self-harm treatment, and potential increases in covered session limits for adults with serious mental illness. File grievances if networks restrict care below what the prevalence data supports.
Notable excerpts
Over 1.5 million lives have been lost to drug overdose and suicide in the past two decades, and many millions more have struggled with mental illness and addiction and their related health, social, and economic impacts. (SAMHSA, July 2026)
In 2025, nearly 45 million Americans, 15.3% of people 12 years or older, met diagnostic criteria for a substance use disorder in the past year. (NSDUH 2025)
Among adults 18 years or older in 2025, 5.3% (13.9 million) reported serious thoughts of suicide in the past year, 1.8% (4.9 million) made a suicide plan. (NSDUH 2025)
In 2025, 11.2% (2.8 million) of adolescents aged 12 to 17 engaged in non-suicidal self-harm in the past year. (NSDUH 2025, first year measured)
View full source text
Read the original policy source.
Primary source text, linked directly.
https://www.samhsa.gov/blog/release-2025-nsduh-using-data-to-drive-great-american-recovery
- Analysis by
- Therapy Companion policy engine
- Confidence
- high
- Analyzed
- July 28, 2026
Related policy changes.
- Relevance score78 / 100
[US] SB4754: Primary and Behavioral Health Care Access Act of 2026
This federal bill could reshape behavioral health workforce, reimbursement, or access policy nationwide. Both chambers now have versions in committee—therapists should track this closely as it progresses.high impact - Relevance score75 / 100
STAT+: HHS presses ahead with effort to curb antidepressant use
Incoming federal clinical guidance on deprescribing could reshape how therapists collaborate with prescribers, increase referrals for therapy-based alternatives, and potentially create new practice opportunities—or reduce medication management referrals. Early insight into this guidance development is critical for practice planning.high impact - Relevance score72 / 100
Opinion: MAHA is rewriting the vocabulary of American mental health care
If HHS-promoted deprescribing becomes standard practice guidance, therapists may see shifts in referral patterns, patient expectations around medication, and potential new billing codes for medication management/tapering counseling. This represents a major philosophical shift in federal mental health approach.high impact - Relevance score72 / 100
[TN] SB1248: AN ACT to amend Tennessee Code Annotated, Title 4; Title 8; Title 33; Title 39; Title 49; Title 53; Title 56; Title 63; Title 68 and Title 71, relative to mental health.
This omnibus bill has potential to reshape Tennessee's mental health landscape across multiple domains. Therapists should monitor committee review closely, as the 10 amended title sections suggest changes to licensing, insurance, workforce development, or scope of practice.high impact
Track what affects your practice.
Therapy Companion tracks both: the policy shifts on this page and the denial patterns hitting your claims.